Clinical Trial Update: Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating autologous adipose-derived mesenchymal stem cells for treatment of stress urinary incontinence in women has completed Phase 1 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Stress Urinary Incontinence | Phase 1, Phase 2 | Status: COMPLETED